Levocarnitine
左卡尼汀
Report date: 2026/05/26 20:00:28
NME
Base Information
Drug NameLevocarnitine
Drug Alias Name +[10]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[34]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1985/12/27
Country/Territory +[10]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSigma-Tau Spa
China Registration ClassN/A
Develop Information
Active CompaniesUniversity of California IrvineLondon Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph'sTanta University +[14]
Inactive CompaniesLee'S Pharmaceutical LtdUniversity Of California San FranciscoBu Ali Hospital +[16]
Active Indications +[19]
Inactive Indications +[15]